Purchases and Sales Made in Q3 2021 in Nautilus Biotechnology, Inc. (NAUT)
This table provides information about the institutional ownership of Nautilus Biotechnology, Inc. (NAUT) during Q3 2021. The information is specifically focused on institutions that hold shares of Nautilus Biotechnology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2021
Q3 2021
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-58.8K- 28.38% |
$361K - $594K
|
148K
$356K
|
|
|
Nov 15, 2021
Q3 2021
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-64.9KClosed |
$398K - $655K
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-93.9K- 6.07% |
$577K - $949K
|
1.45M
$3.49M
|
|
|
Nov 12, 2021
Q3 2021
|
Alpine Global Management, LLC
New York, NY |
SELL
|
- |
-118K- 81.63% |
$722K - $1.19M
|
26.5K
$63.5K
|
|
|
Nov 15, 2021
Q3 2021
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-147K- 12.31% |
$900K - $1.48M
|
1.04M
$2.51M
|
|
|
Nov 16, 2021
Q3 2021
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-161K- 92.54% |
$987K - $1.62M
|
13K
$31.1K
|
|
|
Nov 15, 2021
Q3 2021
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-267KClosed |
$1.64M - $2.7M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Casdin Capital, LLC
New York, NY |
SELL
|
- |
-275K- 55.0% |
$1.69M - $2.78M
|
225K
$540K
|
|
|
Nov 15, 2021
Q3 2021
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-525K- 46.67% |
$3.22M - $5.3M
|
600K
$1.44M
|
|
|
Nov 15, 2021
Q3 2021
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-920K- 64.96% |
$5.65M - $9.29M
|
496K
$1.19M
|